Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03117166 · ClinicalTrials.gov registry record · Phase 1
Effect of Intravenous Lidocaine, Used to Attenuate Pain With Propofol Injection, on Defibrillation Threshold Testing
A Phase 1 study, sponsored by Drexel University College of Medicine.
- Terminated
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
NCT03117166 is a Phase 1 study that was terminated before completion, run by Drexel University College of Medicine. The registered enrollment target is 19 participants.
The verdict
NCT03117166, a Phase 1 study, was terminated before completion, sponsored by Drexel University College of Medicine.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
The use of lidocaine, as an anesthetic drug, during implantation of an implantable cardioverter-defibrillator(ICD)will not result in a clinically significant alteration of the defibrillation threshold during ICD placement.
Interventions
- DRUG Placebo
- DRUG lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2010-01 |
| Est. Completion | 2010-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03117166
The ClinicalTrials.gov registry entry for NCT03117166 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Drexel University College of Medicine, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03117166 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03117166 about?
NCT03117166 is a clinical study titled "Effect of Intravenous Lidocaine, Used to Attenuate Pain With Propofol Injection, on Defibrillation Threshold Testing". The use of lidocaine, as an anesthetic drug, during implantation of an implantable cardioverter-defibrillator(ICD)will not result in a clinically significant alteration of the defibrillation threshold during ICD placement.
What is the current status of trial NCT03117166?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2010-01. Estimated completion is 2010-05.
What interventions are being tested in trial NCT03117166?
The interventions under investigation include: Placebo (DRUG), lidocaine (DRUG).
Who is sponsoring clinical trial NCT03117166?
This trial is sponsored by Drexel University College of Medicine, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.